CME stock: buy or sell?

CME stock price: $178.80 0.35% At close on May 22nd, 2020

Updated on:
May 22nd, 2020


CME closed on Friday at $178.80 and gained a slightly good 0.35%.

CME Group Inc., through its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide.

Should I buy CME stock?

You can't be a successful trader if you don't follow a methodolgy or system that assist you in choosing companies and the correct market timing. Trading strategies are meant for helping you in the decision process of what stocks to pick and when is the best time to buy them. At, we like to use very simple but trusted and powerful trend following trading strategies. Simple things usually work the best.

None of our preferred buy setups matches with CME stock situation right now, hence this is not a suitable entry point.

Buy setupElegible
New all-time highNo
New 52 week highNo
Price crossing up 200d MANo
100d MA crossing up 200d MANo
This doesn't mean CME will fall in coming sessions, or it will not rise higher. Simply, it doesn't match our recommended trading systems.

Is CME stock a buy?

Financial institutions and banks publish stock ratings everyday. Unfortunately, we couldn't find any rating for CME stock for the last month.

CME stock analysis

Daily outlook

Shares of CME ended on Friday at $178.80 and gained a slightly good 0.35%.

Shares of CME ended on Friday at $178.80 and gained a slightly good 0.35%. Since last March when CME stock price broke down the SMA200d line, it slid $-28.21 per share (-13.63%). On February, CME hit a new all time high, pushing higher than on February tops. Check different trading setups that use ATHs as triggers.

CME stock chart (daily)

Weekly outlook

CME closed this week at $178.80 and decreased a lame -1.25%. Early April CME rocketed a super good 8.63% in just one week. Late April CME collapsed a godawful -5.22% in just one week.

Weekly chart tells us that price is in a simple uptrend, tested $170.67 level and now climbing back aiming its last top at $192.27. Not so far away is the last price record CME marked late February, but since then it dropped a 20.35%. Since price and 40-weeks moving average lines crossed down early March, CME fell $-36.61 per share (-17.00%). Trading stocks that are below the 40-weeks (that is, 200-days) moving average mark is not recommended by many experts, as it indicates that the stock has not enough institutional support.

CME stock chart (weekly)

CME stock price history

CME IPO was on December 6th, 2002 at $4.76 per share1. Since then, CME stock grew a 3,656.30%, with a yearly average of 215.10%. If you had invested $1,000 in CME stock in 2002, it would worth $36,563.00 today.

1: Adjusted price after possible price splits or reverse-splits.

CME stock historical price chart

CME stock reached all-time highs on February with a price of $224.47.

CME stock price target

How much a stock will be priced tomorrow or next week is quite unpredictable However, banks and other financial institutions analysts, with the help of lots of data and algorithms do their best to predict the stock prices movement. The accuracy of these stock price predictions is not very high, and you should not blindly believe and make decisions only based on what this ratings or price target predictions say. For the last month we have not detected any price target for CME stock by any trusted analyst.

Financials and fundamental analysis

Earnings date and Earnings per Share

After presenting its last earnings report , CME . Unfortunately, reported EPS is not yet available in our database.
CME earnings date and EPS evolution
QuarterReporting dateEstimated EPSActual EPSSurprise

Annual financial results

In 2018, CME annual turnover skyrocketed an outstanding 18.24% to $4,309.40 M USD from $3,644.70 marked in 2017. On the other hand, its earnings margin (compared to sales) plummed to 45.53%, that is $1,962.20 million.

CME annual Sales and Income evolution
2013$2,930 M-$977 M33.3%-
2014$3,113 M6.23%$1,127 M36.2%15.39%
2015$3,327 M6.89%$1,247 M37.5%10.64%
2016$3,595 M8.07%$1,534 M42.7%23.02%
2017$3,645 M1.38%$4,063 M111.5%164.87%
2018$4,309 M18.24%$1,962 M45.5%-51.71%

Quarterly financial results

CME posted $1,236.60 M in sales for 2018-Q4, a 36.76% improvement compared to previous quarter. Reported quarter earnings marked $385.50 M with a profit margin of 31.17%. Profit margin plunged a -14.37% compared to previous quarter when profit margin was 45.54%. When comparing revenues to same quarter last year, CME sales marked an exceptional growth and rocketed a 37.40%.
CME quarterly Sales and Income evolution
2017-Q2$925 M-$416 M45.0%-
2017-Q3$891 M-3.66%$309 M34.6%-25.78%
2017-Q4$900 M1.03%$2,939 M326.6%852.43%
2018-Q1$1,109 M23.22%$599 M54.0%-79.63%
2018-Q2$1,060 M-4.45%$566 M53.4%-5.46%
2018-Q3$904 M-14.67%$412 M45.5%-27.26%
2018-Q4$1,237 M36.76%$386 M31.2%-6.39%
2019-Q1$1,180 M-4.61%$497 M42.1%28.90%

CME ownership

Checking CME ownership structure gives valuable information about the company and its governance (insider ownership) or the amount of investors that are on the short side.

Management staff in all public traded companies that hold equity is required to report every transaction to the SEC. For CME, 1.56% of all outstanding shares are owned by its staff.

Bearish positions for CME stock account 0.00%, no big difference from last month.

For a better context understanding, the following table shows ownership data compared to other related stocks:

Market cap$64.1 B
Total shares358.6 M
Float shares349.6 M
  - Institutional holdings (%)88.0%
  - Insider holdings (%)1.6%
Shares in short selling0.0%

CME summary

Friday, May 22nd, 2020
Day range$176.02 - $178.98
Previous close$178.18
Session gain0.35%
Average true range$5.56
50d mov avg$175.35
100d mov avg$191.76
200d mov avg$197.95
Daily pattern
Weekly pattern lb01a

CME performance

Stocks performance is always measured in comparision to the market or competitors and related stocks in the same industry. We compared CME against in the following table:
CME -14.04%-11.84%-2.24%

CME competitors

Unfortunately, we could not find any public company that could be defined as CME competitor. This doesn't mean CME does not have any competitor in the market, it's just we could not detected it.

    Latest CME stock news